Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Prockop

Showing results (171-180 of 266) with videos related to

Pageof 27
Sort By:
The Journal of Biological Chemistry|December 15, 1988
A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm awayB E Vogel, R Doelz, K E Kadler, et al.
British Journal of Haematology|December 3, 1999
Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiateC M Digirolamo, D Stokes, D Colter, et al.
The Journal of Biological Chemistry|September 25, 1980
Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VIIB Steinmann, L Tuderman, L Peltonen, et al.
American Journal of Human Genetics|November 1, 1984
Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfectaP Tsipouras, A L Børresen, L A Dickson, et al.
Biochemical Society Transactions|August 30, 2000
Potential use of stem cells from bone marrow to repair the extracellular matrix and the central nervous systemD J Prockop, S A Azizi, D Colter, et al.
Gene Therapy|April 9, 2005
Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defectsR R Pochampally, E M Horwitz, C M DiGirolamo, et al.
The Journal of Biological Chemistry|April 15, 1994
Self-assembly of collagen I from a proband homozygous for a mutation that substituted serine for glycine at position 661 in the alpha 2(I) chain. Possible relationship between the effects of mutations on critical concentration and the severity of the phenotypeA M Romanic, L D Spotila, E Adachi, et al.
American Journal of Human Genetics|March 7, 1998
Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutationsJ Körkkö, L Ala-Kokko, A De Paepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1991
Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasiaP Vandenberg, J S Khillan, D J Prockop, et al.
Blood|March 9, 1999
Human immunodeficiency virus type 1 Vpr alters bone marrow cell functionJ Kulkosky, A Laptev, S Shetty, et al.
Pageof 27

Showing results (171-180 of 266) with videos related to

Sort By:
Pageof 27
The Journal of Biological Chemistry|December 15, 1988
A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm awayB E Vogel, R Doelz, K E Kadler, et al.
British Journal of Haematology|December 3, 1999
Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiateC M Digirolamo, D Stokes, D Colter, et al.
The Journal of Biological Chemistry|September 25, 1980
Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VIIB Steinmann, L Tuderman, L Peltonen, et al.
American Journal of Human Genetics|November 1, 1984
Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfectaP Tsipouras, A L Børresen, L A Dickson, et al.
Biochemical Society Transactions|August 30, 2000
Potential use of stem cells from bone marrow to repair the extracellular matrix and the central nervous systemD J Prockop, S A Azizi, D Colter, et al.
Gene Therapy|April 9, 2005
Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defectsR R Pochampally, E M Horwitz, C M DiGirolamo, et al.
The Journal of Biological Chemistry|April 15, 1994
Self-assembly of collagen I from a proband homozygous for a mutation that substituted serine for glycine at position 661 in the alpha 2(I) chain. Possible relationship between the effects of mutations on critical concentration and the severity of the phenotypeA M Romanic, L D Spotila, E Adachi, et al.
American Journal of Human Genetics|March 7, 1998
Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutationsJ Körkkö, L Ala-Kokko, A De Paepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1991
Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasiaP Vandenberg, J S Khillan, D J Prockop, et al.
Blood|March 9, 1999
Human immunodeficiency virus type 1 Vpr alters bone marrow cell functionJ Kulkosky, A Laptev, S Shetty, et al.
Pageof 27